Condition | Cardiology

Canakinumab

  • Contact Name: Center for Clinical Research
  • Status: Active / Closed to Enrollment
  • Phone: 585.922.3536
  • Lead Researcher: Gerald Gacioch, MD

Description

Study of post-myocardial infarction (heart attack) drug to prevent future cardiovascular events using interleukin anti-body to reduce cardiovascular inflammation

http://clinicaltrials.gov/ct2/show/study/NCT01327846?term=canakinumab+hsCRP&rank=1&show_locs=Y#locn

Sponsor: Novartis Pharmaceutical

Keywords: MI, myocardial infarction, heart attack, heart disease, heart, cardiac, canakinumab, Novartis, Cantos, anti-inflammatory, drug, cardiovascular